1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. News
  7. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
Delayed Nasdaq Stockholm  -  05/20 11:29:32 am EDT
286.00 SEK   +0.39%
04/27Getinge To Buy France's FLUOPTICS in $27.4 Million Deal
MT
04/27GETINGE : to acquire FLUOPTICS, a technology leader in the area of Near Infrared Imaging
PU
04/27GETINGE AB : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Getinge appoints Patricia Fitch as President North America Region

01/17/2022 | 09:01am EDT

Getinge appoints Patricia Fitch as President North America Region. Patricia succeeds Eric Honroth who has been appointed President Life Science at Getinge.

Patricia Fitch joined Getinge in March 2021 as Vice President US Sales covering the Acute Care Therapies division. Patricia has more than 30 years of medical device experience, having held leadership roles in sales, marketing and operations with multi-national corporations such as Johnson & Johnson, Abiomed, St. Jude Medical and 3M.

Eric Honroth has been appointed President Life Science and member of the Getinge Executive team. Eric joined Getinge 2018 and will succeed Harald Castler, who after a long and successful career in Getinge has decided to retire.

All changes are effective as of April 1, 2022.


Media contact
Anna Appelqvist, VP Corporate Communications
Phone: +46 734 244 527
Email: anna.appelqvist@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

https://news.cision.com/getinge/r/getinge-appoints-patricia-fitch-as-president-north-america-region,c3487396

https://mb.cision.com/Main/942/3487396/1521281.pdf

https://news.cision.com/getinge/i/patricia-fitch,c3000666

(c) 2022 Cision. All rights reserved., source Press Releases - English

All news about GETINGE AB
04/27Getinge To Buy France's FLUOPTICS in $27.4 Million Deal
MT
04/27GETINGE : to acquire FLUOPTICS, a technology leader in the area of Near Infrared Imaging
PU
04/27GETINGE AB : Ex-dividend day for final dividend
FA
04/26Resolutions at Getinge's Annual General Meeting 26 April 2022
AQ
04/26Getinge AB Declares Dividend for 2021, Payable on May 3, 2022
CI
04/26European stocks slide with eyes on U.S. tech earnings
RE
04/26TRANSCRIPT : Getinge AB, Q1 2022 Earnings Call, Apr 26, 2022
CI
04/26GETINGE : Presentation Q1 2022 Report
PU
04/26Medical gear maker Getinge's profit falls on supply chain trouble
RE
04/26Medical gear maker Getinge's profit falls on supply chain trouble
RE
More news
Analyst Recommendations on GETINGE AB
More recommendations
Financials
Sales 2022 29 546 M 2 966 M 2 966 M
Net income 2022 3 563 M 358 M 358 M
Net Debt 2022 2 216 M 222 M 222 M
P/E ratio 2022 21,9x
Yield 2022 1,59%
Capitalization 77 898 M 7 819 M 7 819 M
EV / Sales 2022 2,71x
EV / Sales 2023 2,46x
Nbr of Employees 10 892
Free-Float 79,8%
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 286,00 SEK
Average target price 415,67 SEK
Spread / Average Target 45,3%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandstr÷m Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB-27.61%7 819
MASIMO CORPORATION-51.71%7 839
NOVOCURE LIMITED-0.51%7 813
SHOCKWAVE MEDICAL, INC.-11.25%5 665
PENUMBRA, INC.-50.59%5 349
IRAY TECHNOLOGY COMPANY LIMITED-22.53%4 173